The CEPI centralised laboratory network: supporting COVID-19 vaccine development.

Kumar, Arun; Bernasconi, Valentina; Manak, Mark; de Almeida Aranha, Ana Paula; Kristiansen, Paul A

Kumar, Arun; Bernasconi, Valentina; Manak, Mark; de Almeida Aranha, Ana Paula; Kristiansen, Paul A.

Afiliación

Kumar A; Vaccine Research and Development, Coalition for Epidemic Preparedness Innovations, Oslo 0473, Norway. Electronic address: arun.kumar@cepi.net.
Bernasconi V; Vaccine Research and Development, Coalition for Epidemic Preparedness Innovations, Oslo 0473, Norway.
Manak M; Vaccine Research and Development, Coalition for Epidemic Preparedness Innovations, Oslo 0473, Norway.
de Almeida Aranha AP; Vaccine Research and Development, Coalition for Epidemic Preparedness Innovations, Oslo 0473, Norway.
Kristiansen PA; Vaccine Research and Development, Coalition for Epidemic Preparedness Innovations, Oslo 0473, Norway.

Lancet ; 397(10290): 2148-2149, 2021 06 05.

Article en En | MEDLINE | ID: mdl-34090600

Asunto(s)

Vacunas contra la COVID-19/provisión & distribución; COVID-19/prevención & control; Inmunogenicidad Vacunal; Internacionalidad; Laboratorios/normas; Humanos; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Internacionalidad / Inmunogenicidad Vacunal / Vacunas contra la COVID-19 / COVID-19 / Laboratorios Límite: Humans Idioma: En Revista: Lancet Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google